StockData
Johnson & Johnson logo

Johnson & Johnson

JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3043% above fair value
$270.56−2.64 (-0.97%)

Close on Nov 2, 2026Market cap $652.02BP/E 31.4Yield 1.90%

Johnson & Johnson Oral Care (LISTERINE) — Worldwide sales by Quarter

Oral Care (LISTERINE) — Worldwide sales ($M) ($M)

Johnson & Johnson Oral Care (LISTERINE) — Worldwide sales: $398M in Q2 2023, up 1.0% from a year earlier. No newer figure appears in the documents we track.

Latest, Q2 2023
398
Period ended Jul 2, 2023
Change on a year earlier
+1.0%
394 in Q2 2022
History
27 quarters
Since Q4 2016
Sources
19
Documents cited below

Where the Q2 2023 figure comes from

Source: Form 10-Q (filed 2023-07-31) ↗

Reported in Form 10-Q / 10-K Segment Note & Form 8-K EX-99.2 Segment Sales Schedule.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedOral Care (LISTERINE) — Worldwide sales ($M) ($M)Year on yearSource
Q2 2023Jul 2, 2023398+1.0%Form 10-Q (filed 2023-07-31) ↗
Q1 2023Apr 2, 2023361-1.4%Form 10-Q (filed 2023-04-28) ↗
Q4 2022Jan 1, 2023370-8.6%Form 10-K (filed 2023-02-16) ↗
Q3 2022Oct 2, 2022375-5.8%Form 10-Q (filed 2022-10-27) ↗
Q2 2022Jul 3, 2022394-7.5%Form 10-Q (filed 2023-07-31) ↗
Q1 2022Apr 3, 2022366-12.2%Form 10-Q (filed 2023-04-28) ↗
Q4 2021Jan 2, 2022405-7.3%Form 10-K (filed 2023-02-16) ↗
Q3 2021Oct 3, 2021398-3.4%Form 10-Q (filed 2022-10-27) ↗
Q2 2021Jul 4, 2021426+7.3%Form 10-Q (filed 2022-07-29) ↗
Q1 2021Apr 4, 2021417+5.6%Form 10-Q (filed 2022-04-29) ↗
Q4 2020Jan 3, 2021437+11.2%Form 10-K (filed 2023-02-16) ↗
Q3 2020Sep 27, 2020412+8.7%Form 10-Q (filed 2021-10-29) ↗
Q2 2020Jun 28, 2020397-62.7%Form 10-Q (filed 2021-07-29) ↗
Q1 2020Mar 29, 2020395+7.6%Form 10-Q (filed 2021-04-30) ↗
Q4 2019Dec 29, 2019393-1.5%Form 10-K (filed 2022-02-17) ↗
Q3 2019Sep 29, 2019379-1.3%Form 10-Q (filed 2020-10-23) ↗

Breakdown

What makes up oral Care (LISTERINE) — Worldwide sales

Cite this data

StockData. (2026). Johnson & Johnson Oral Care (LISTERINE) — Worldwide sales ($M), quarterly Q4 2016–Q2 2023 [Data set]. Compiled from Johnson & Johnson SEC filings and investor materials. https://stockdatahq.com/stocks/jnj/kpis/ch-oral-care

See every metric in the Johnson & Johnson KPI table. Data updated Oct 25, 2026.